ImmuCell
ICCC
22 hedge funds and large institutions have $7.34M invested in ImmuCell in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
0% more funds holding
Funds holding: 22 → 22 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
2.34% less ownership
Funds ownership: 22.12% → 19.78% (-2.3%)
17% less capital invested
Capital invested by funds: $8.86M → $7.34M (-$1.51M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$224K |
| 2 |
SFS
Strategic Financial Services
Utica,
New York
|
+$145K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$77.2K |
| 4 |
Renaissance Technologies
New York
|
+$72.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.83K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$975K |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$364K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$119K |
| 4 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.38K |
ICCC Hedge Fund Activity: Q4 2019 in Review
22 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2019, worth a combined $7.34M — down 17% from $8.86M a quarter earlier.
Fund positioning in ICCC was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $224K. The largest seller was Heartland Advisors, exiting entirely with an estimated $975K sold.
- 22 institutional investors held ImmuCell (ICCC) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $7.34M of ImmuCell stock for Q4 2019, down 17% quarter-over-quarter.
- 4 funds opened new ImmuCell positions in Q4 2019 and 4 closed out, a net change of 0 holders.
- The largest ImmuCell buyer in Q4 2019 was Morgan Stanley, an estimated $224K added.
- The largest ImmuCell seller in Q4 2019 was Heartland Advisors, an estimated $975K sold.
Based on aggregated 13F filings for Q4 2019.